• BioLineRx Ltd., of Jerusalem, reported that preclinical results demonstrated that BL-7010, a polymer intended to treat celiac disease, reduced gluten toxicity and prevented gluten-induced pathological damage to the small intestine in rodents. The research was published in the February 2012 edition of Gastroenterology.